References
- Serenius F, Källén K, Blennow M, EXPRESS Group, et al. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden. JAMA. 2013;309:1810–1820.
- Kemp MW, Newnham JP, Challis JG, et al. The clinical use of corticosteroids in pregnancy. Hum Reprod Update. 2016;22:240–259.
- Serenius F, Blennow M, Mar al K, et al. Intensity of perinatal care for extremely preterm infants: outcomes at 2.5 years. Pediatrics. 2015;135:e1163–e1172.
- Conde-Agudelo A, Romero R, Kusanovic JP. Nifedipine in the management of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011;204:134.e1–134.20.
- Roberts D, Brown J, Medley N, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3(3):CD004454.
- Lyell DJ, Pullen K, Campbell L, et al. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor. Obstet Gynecol. 2007;110:61–67.
- Papatsonis DN, Flenady V, Liley HG. Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour. Cochrane Database Syst Rev. 2013;10:CD005938.
- Kashanian M, Bahasadri S, Zolali B. Comparison of the efficacy and adverse effects of nifedipine and indomethacin for the treatment of preterm labor. Int J Gynecol Obstet. 2011;113:192–195.
- Kashanian M, Akbarian AR, Soltanzadeh M. Atosiban and nifedipin for the treatment of preterm labor. Int J Gynecol Obstet. 2005;91:10–14.
- Vogel JP, Nardin JM, Dowswell T, et al. Combination of tocolytic agents for inhibiting preterm labour. Cochrane Database Syst Rev. 2014;7:CD006169.
- Kashanian M, Zamen Z, Sheikhansari N. Comparison between nitroglycerin dermal patch and nifedipine for treatment of preterm labor: a randomized clinical trial. J Perinatol. 2014;34:683–687.
- Abasalizadeh S, Azar Fakhraei M, Ghojazadeh M, et al. Compare the efficacy of indomethacin and magnesium sulphate in prevention of preterm labor. Int J Curr Res Acad Rev. 2014;2(8).
- Flenady V, Wojcieszek AM, Papatsonis DN, et al. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database Syst Rev. 2014;6:CD002255.
- Caritis S. Adverse effects of tocolytic therapy. BJOG Int J Obstet Gynaecol. 2005;112:74–78.
- Gáspár R, Hajagos-Tóth J. Calcium channel blockers as tocolytics: principles of their actions, adverse effects and therapeutic combinations. Pharmaceuticals. 2013;6:689–699.
- Souter D, Harding J, McCowan L, et al. Antenatal indomethacin–adverse fetal effects confirmed. Aust N Z J Obstet Gynaecol. 1998;38:11–16.
- de Heus R, Mol BW, Erwich JJ, et al. Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study. BMJ. 2009;338:b744.
- Loe SM, Sanchez-Ramos L, Kaunitz AM. Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet Gynecol. 2005;106:173–179.
- Savage AH, Anderson BL, Simhan HN. The safety of prolonged indomethacin therapy. Amer J Perinatol. 2007;24:207–213.
- Kuć P, Laudański P, Pierzyński P, et al. The effect of combined tocolysis on in vitro uterine contractility in preterm labour. Adv Med Sci. 2011;56:88–94.
- Carvajal JA, Zambrano MJ, Theodor NM, et al. The synergic in vitro tocolytic effect of nifedipine plus ritodrine on human myometrial contractility. Reprod Sci. 2017;24:635–640.
- Doret M, Mellier G, Gaucherand P, et al. The in vitro effect of dual combinations of ritodrine, nicardipine and atosiban on contractility of pregnant rat myometrium. BJOG. 2003;110:731–734.
- Doret M, Mellier G, Benchaib M, et al. In vitro study of tocolytic effect of rofecoxib, a specific cyclo-oxygenase 2 inhibitor. Comparison and combination with other tocolytic agents. BJOG. 2002;109:983–988.
- Grignaffini A, Soncini E, Ronzoni E, et al. Clinical practice evaluation of combination of atosiban, ritodrine and ketoprofen for inhibiting preterm labor. Minerva Ginecol. 2007;59:481–489.